[Clinical pathway for electrical storm treatment in a healthcare network modeling. A proposal from ANMCO Tuscany].

Percorso clinico-assistenziale in rete per il trattamento del paziente con “storm” aritmico. La proposta dell’ANMCO Toscana.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
Oct 2020
Historique:
entrez: 24 9 2020
pubmed: 25 9 2020
medline: 16 7 2021
Statut: ppublish

Résumé

Electrical storm (ES) is defined as three or more episodes of sustained ventricular tachycardia (VT) or fibrillation (VF) within 24 h, or an incessant VT/VF lasting more than 12 h. It usually occurs in implantable cardioverter-defibrillator (ICD) recipients, and three or more device interventions are typically used for the diagnosis. ES incidence is particularly high in case of ICD implanted in secondary prevention (10-30%), with recurrences occurring in up to 80% of patients. A comprehensive evaluation of triggers, predictive factors of high-risk patients and an appropriate management of the acute/subacute and chronic phases are pivotal to reduce mortality and recurrences. Medical therapy with antiarrhythmic and anesthetic drugs, with appropriate device reprogramming and neuroaxial modulation if needed, are used to cool down the ES, which should ultimately be treated with ablation therapy or, less often, with an alternative treatment, such as denervation or stereotactic radiosurgery. An optimization of the clinical pathway in a network modeling is crucial to achieve the best treatment, eventually addressing patients to centers with VT ablation programs, and identifying the most challenging procedures and the most critical patients that should be treated only in high-volume tertiary centers. In this paper, we present a proposal of healthcare network modeling for ES treatment in a regional setting.

Identifiants

pubmed: 32968314
doi: 10.1714/3431.34203
doi:

Substances chimiques

Anesthetics 0
Anti-Arrhythmia Agents 0

Types de publication

Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

768-778

Auteurs

Giulio Zucchelli (G)

U.O.C. Cardiologia 2, Azienda Ospedaliero-Universitaria Pisana, Pisa.

Maria Grazia Bongiorni (MG)

U.O.C. Cardiologia 2, Azienda Ospedaliero-Universitaria Pisana, Pisa.

Luca Segreti (L)

U.O.C. Cardiologia 2, Azienda Ospedaliero-Universitaria Pisana, Pisa.

Andrea Di Cori (A)

U.O.C. Cardiologia 2, Azienda Ospedaliero-Universitaria Pisana, Pisa.

Ezio Soldati (E)

U.O.C. Cardiologia 2, Azienda Ospedaliero-Universitaria Pisana, Pisa.

Francesco De Sensi (F)

U.O.C. Cardiologia, Ospedale Misericordia, Grosseto.

Stefano Lunghetti (S)

U.O.C. Cardiologia. Policlinico Le Scotte, Siena.

Silvia Forni (S)

Agenzia Regionale di Sanità (ARS) della Toscana, Firenze.

Claudia Szasz (C)

Agenzia Regionale di Sanità (ARS) della Toscana, Firenze.

Giancarlo Casolo (G)

U.O.C. Cardiologia, Nuovo Ospedale Versilia, USL Toscana Nord Ovest, Lido di Camaiore (LU).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH